3 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 3 |
Follow Dordaviprone (ONC201): new trials by email Literature Review of Dordaviprone (ONC201) trials Research Report on Dordaviprone (ONC201)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ONC201 in Recurrent or Metastatic Type II Endometrial Cancer Endometrial Cancer Dordaviprone (ONC201) - Endometrial Cancer Recurrent | Phase 2 | Terminated | Jazz Pharmaceuticals | 27 | 2018-03-21 | 2024-12-24 |
| ONC201 in Adults With Recurrent H3 K27M-mutant Glioma Dordaviprone (ONC201) - Glioma | Phase 2 | Terminated | Jazz Pharmaceuticals | 73 | 2017-10-30 | 2025-07-28 |
| Oral ONC201 in Adult Recurrent Glioblastoma Dordaviprone (ONC201) - Glioblastoma, Diffuse Midline Glioma | Phase 2 | Terminated | Jazz Pharmaceuticals | 84 | 2016-01-01 | 2024-12-24 |
Glioblastoma (1) · Glioma (1)
United States (3)